How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your individual metabolic and appetite-regulation predispositions by analyzing key variants in pathways like GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)
IGF-1 LR3 has no human body composition RCT data at all
Merriam GR, Schwartz RS, Vitiello MV
Weight loss varies depending on the dose and type of medication, with differences observed in head-to-head studies [117]
Common side effects of these GLP-1 drugs include nausea, vomiting, and stomach discomfort
Hypoglycaemia risk When combined with diabetes medications, particularly insulin or sulfonylureas, berberine may potentiate glucose-lowering effects, increasing hypoglycaemia risk